Express Healthcare
Home  »  News  »  Honeywell begins production of disposable face masks at Fulgaon facility, Pune

Honeywell begins production of disposable face masks at Fulgaon facility, Pune

0 145
Read Article

Honeywell has begun production of up to 2 million disposable face masks monthly at its Fulgaon manufacturing facility in Pune, India.

According to a release, the masks will be supplied to frontline healthcare workers, emergency responders and government organisations as part of the efforts to combat COVID-19 in India. The masks are designed in alignment with India Bureau of Indian Standards and US National Institute for Occupational Safety and Health (NIOSH) standards.

“Honeywell’s initiative to commence production of N95 respirators at its Pune facility is a major step towards supporting the country in this fight against COVID-19,” said Amitabh Kant, CEO, NITI Aayog. “We encourage the industry to promote domestic manufacturing of masks in making India’s healthcare ecosystem self-reliant. With companies and citizens joining hands, we will be able to win the war against COVID-19.”

“As a global leader in manufacturing superior quality personal protective equipment, Honeywell is proud to manufacture superior quality face masks to protect frontline healthcare workers in their fight against the global pandemic,” said Akshay Bellare, president, Honeywell India. “We are committed to India’s mission to be a self-reliant nation and bring our technical capabilities to support frontline workers in their efforts to help those in need.”

“We are proud of our team for setting up a highly advanced production line with physical capacity and technical capabilities to manufacture the face masks that are designed to meet NIOSH standards.  These masks will help address the country’s need for high-quality protection gear in high demand during this healthcare crisis,” said Asheesh Arora, vice president and general manager, Honeywell Safety and Productivity Solutions, APAC.

Honeywell has recruited and trained approximately 40 new workers to run the production line.

Watch Video:

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More